Icosavax Inc (ICVX) - News Archive

Showing 2 of 2 results.

AstraZeneca Strengthens Late-Stage Vaccine Pipeline with Acquisition of Icosavax: Paving the Way for Breakthrough RSV and hMPV Combination Vaccine

In a significant move to bolster its position in the biopharmaceutical arena, AstraZeneca has recently announced its definitive agreement to acquire Icosavax, Inc. The Delaware-based clinical-stage biopharmaceutical com...

Dec 12, 2023 • Biotechnology & Pharmaceuticals Industry Merger and Acquisition NASDAQ

Big Step Forward in Respiratory Virus Prevention: Icosavax’s Landmark Phase 2 Vaccine Results Promising for Older Adults' Protection.

In the pursuit of the ultimate way to combat RSV and hMPV, the combination VLP vaccine, IVX-A12, is a blend of two vaccines previously being developed separately the IVX-RSV and the IVX-hMPV. The combination of these tw...

Dec 12, 2023 • Biotechnology & Pharmaceuticals Industry Clinical Study icosavax